GreenLight Biosciences's current assets is $38M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2023), GRNA shows a current assets of $38M. That compares with $97M in the prior-year period — down 61.1% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, GRNA's current assets is now $38M (was $97M) — a 61.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether GreenLight Biosciences is outperforming or lagging.
Tracking GRNA's current assets over time shows whether GreenLight Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $38M That compares with $97M in the prior-year period — down 61.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this current assets page, Stockcircle has GreenLight Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $38M) with ownership activity and broader fundamentals.